zantac

Dismissal Affects Over 50,000 Cancer Claims Against Zantac A federal judge overseeing multi-district litigation (MDL) has dismissed more than 50,000 Zantac lawsuits, alleging that the popular heartburn medication caused various types of cancer. In her decision, Judge Robin Rosenburg found that experts testifying on behalf of plaintiffs failed to demonstrate...
Read More

Zantac was once one of the most popular heartburn medications on the market. However, after a probable human carcinogen, N-Nitrosodimethylamine (NDMA), was found in Zantac, it triggered a slew of Zantac lawsuits and a nationwide recall. Now, consumers have deep concerns about the safety of this product. Of course, the...
Read More

Following a wave of consumer lawsuits against the makers of popular heartburn medication Zantac, a California state court judge has scheduled the first Zantac trial. The first Zantac “bellwether” trial is set to take place on October 10, 2022, in Oakland, California. First Zantac Bellwether Trial This is the first...
Read More

There is huge news in Zantac cancer lawsuits. In early July 2021, a federal court ruled against plaintiffs in generic Zantac lawsuits, saying that manufacturers of generic Zantac cannot face litigation alleging that their generic ranitidine causes cancer. The ruling affects thousands of lawsuits alleging that generic versions of Zantac...
Read More